Article Exclusively Authored by Industry Regulators
The FDA has released a final guidance on how companies should present quantitative information about the risks and effectiveness of drugs in direct-to-consumer advertising. The guidance, which was cleared by the White House four months ago, includes changes in the way information about control groups should be presented in drug advertisements. The FDA’s Center for […]